drugset

drugset / Trial / NCT04975347

Opioid Antagonism in Individuals Ascertained Through the Partners HealthCare Biobank

NCT04975347 ↗

Phase 1 Completed 47 enrolled Massachusetts General Hospital

Non-randomizedParallel-groupOpen-labelOther

Summary

The goal of this study is to evaluate the effects of opioid antagonists on the hypothalamic-pituitary-gonadal axis in healthy subjects.

Timeline

Start: 2022-06-03
Primary completion: 2025-08-08
Completion: 2025-08-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Naloxone	Small molecule	—	Intravenous

Indications